Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage
CNS Neuroscience & Therapeutics · 2025-04 · 31 (4)
DOI: 10.1111/cns.70385 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.04.2025. Verfasst von Ari Misael Martínez-Torres und 2 weiteren Autor:innen. Beteiligte Einrichtung: División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Cerebral Hemorrhage, NADPH Oxidase 2, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Consejo Nacional de Humanidades, Ciencias y Tecnologías.
Abstract (Originalsprache)
Background
Intracerebral hemorrhage (ICH) is a leading cause of death and disability worldwide. Following the initial mechanical injury caused by hematoma expansion, a secondary injury occurs, characterized by the production of reactive oxygen species (ROS) generated by NOX‐2 and neuroinflammation, which is exacerbated by the upregulation of the NLRP3 inflammasome. These conditions collectively aggravate brain damage. The endocannabinoid system (ECS), through the activation of the cannabinoid receptors, has demonstrated neuroprotective properties in various models of brain injury. However, the role of the ECS during ICH remains poorly understood, particularly regarding the action of the CB1 receptor in the activation of NOX‐2 and the inflammasome. The present study investigates the neuroprotective effects of the cannabinoid receptor agonist WIN55,212‐2 in an ICH animal model, specifically examining the roles of NLRP3 and NOX‐2.
Methods
Male C57BL/6 mice were subjected to ICH through an intracerebral injection of collagenase, followed by intraperitoneal administration of WIN55,212‐2 and/or MCC950, a selective NLRP3 inhibitor. Various outcome measures were employed, including assessments of motor activity, hematoma volume, brain water content, and blood–brain barrier (BBB) permeability, which was evaluated using Evans blue assay. Additionally, the activity of NOX and the protein levels of crucial markers such as CB1, gp91phox, NLRP3, AQP4, and caspase‐1 were measured via western blot analysis.
Result
The findings demonstrate that ICH induced a significant brain lesion characterized by hematoma formation, edema, BBB disruption, and subsequent motor impairments in the affected mice. Notably, these detrimental effects were markedly reduced in animals treated with WIN55,212‐2. The study also revealed an activation of both NOX‐2 and NLRP3 in response to ICH, which was reduced by cannabinoid receptor activation. Furthermore, the pharmacological inhibition of NLRP3 using MCC950 also led to a reduction in hematoma size, edema, and motor impairment secondary to ICH.
Conclusions
These results support a neuroprotective role of the cannabinoid receptor activation during ICH and suggest the involvement of NOX‐2 and NLRP3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México.
ORCID-Profile: Julio Morán
Förderung
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
Zitieren
APA
Martínez-Torres, A. M., Ramírez-Celis, C., & Morán, J. (2025). Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics, 31(4). https://doi.org/10.1111/cns.70385
Vancouver
Martínez-Torres AM, Ramírez-Celis C, Morán J. Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. 2025;31(4). doi:10.1111/cns.70385
BibTeX
@article{MartnezTorres2025,
author = {Martínez-Torres, Ari Misael and Ramírez-Celis, Crisalde and Morán, Julio},
title = {Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {4},
doi = {10.1111/cns.70385}
}
EUVIMED